. 2021 Feb 23;16(2):e0243183. doi: 10.1371/journal.pone.0243183

Table 2. Results of clinical NPS sample evaluation using QuantiVirus^™ SARS-CoV-2 test.

Patients samples	N	SARS-CoV-2		Sensitivity (95% CI)	Specificity (95% CI)	PPV (95% CI)	NPV (95% CI)
Patients samples	N	Detected	Not Detected	Sensitivity (95% CI)	Specificity (95% CI)	PPV (95% CI)	NPV (95% CI)
Positive	85	84	1	98.8% (0.927–0.999)	100% (0.949–1.00)	100% (0.946–1.00)	98.9% (0.931–0.999)
Negative	90	0	90	98.8% (0.927–0.999)	100% (0.949–1.00)	100% (0.946–1.00)	98.9% (0.931–0.999)

* ABI QuantStudio 5 qPCR instrument was used for this test.

Table 2. Results of clinical NPS sample evaluation using QuantiVirus™ SARS-CoV-2 test.